Announced Tue, 31 Mar · 15:08 IST

Submission of Intimation of Resignation of Director of the Company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.4%1-day move
₹55.78
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.4-8.7-9.8-5.0+8.2-2.7-0.5-1.6-1.8+39.8
Up moveDown movePending
AI summary

Novelix Pharmaceuticals has informed the stock exchange that Mr. Jivamohan Divakar Valluri (DIN: 09218013) has resigned from the Board as a Non-Executive Non-Independent Director, effective from the close of business hours on 30th March 2026. The resignation was approved in a board meeting held on the same day at the company's registered office in Hyderabad. Mr. Valluri cited pre-occupation and other personal commitments as the reason for stepping down, and confirmed there are no material reasons behind the exit. He also steps down from the Audit Committee, Nomination & Remuneration Committee, and as Chairperson of the Stakeholders' Relationship Committee. He does not hold directorship in any other listed entity.

Likely market impact

The departure of a single non-executive director for personal reasons is a routine board-level change with limited impact on the stock. Shareholders should watch for timely appointment of a replacement director, particularly on the Stakeholders' Relationship Committee where he was the Chairperson.